Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b7e0de8c197e97c55ac66c10ae73f10a http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_4115aebe72f44fa758dc5afc60e2693d |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B59-002 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D471-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D491-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K51-00 |
filingDate |
2007-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b10d77176a102947a649d53aa0e732ff http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fe89dd1e4ff7bb359da0480addc62b67 |
publicationDate |
2012-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
US-8226927-B2 |
titleOfInvention |
11C/18F-labeled inhibitors of glycogen synthase kinase-3 |
abstract |
The present invention relates to new 11 C/ 18 F-labeled inhibitor compounds for over-expressed GSK-3 prepared from the GMP synthesis method. The present invention provides novel 11 C/ 18 F inhibitor compounds for over-expressed GSK-3 that are suitable for use as an in vivo imaging agent. A pharmaceutical comprising the compound and a kit for the preparation of the pharmaceutical are also provided. |
priorityDate |
2006-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |